ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025
Assessment of Adipokine and Inflammation Biomarkers with Cancer Risk among Chinese Men: A Prospective Cohort Study.
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundObesity and chronic inflammation are associated with cancer risk. We investigated the association between adipokines, inflammation markers, and cancer risk in Chinese men.
methodsUsing prediagnostic fasting plasma samples from 4,051 (6.6%) participants of the Shanghai Men's Health Study, ages 40 to 74 years, recruitted during 2002 to 2006, we evaluated the associations of inflammation biomarkers with risk of all cancers and top four cancers among Chinese men: lung, stomach, liver, and colorectal cancers. Levels of leptin, resistin, adiponectin, plasminogen activator inhibitor type 1, IL-6, IL-8, IL-1β, TNFα, monocyte chemoattractant protein 1, and insulin were measured using Luminex assays and C-reactive protein (CRP) using the ACE Clinical Chemistry System. Cox regression models were applied to derive adjusted HRs (aHR) and 95% confidence intervals (CI) for cancer risk in association with per-log-unit and tertile increment of biomarker levels.
resultsAfter adjusting for known cancer risk factors, the third versus first tertile of TNFα (aHR = 1.78; 95% CI, 1.04-3.05) was associated with lung cancer, whereas leptin (aHR = 3.00; 95% CI, 1.23-7.25), insulin (aHR = 2.26; 95% CI, 1.04-4.54), and CRP (aHR = 2.24; 95% CI, 1.16-4.32) levels were each associated with colorectal cancer. Per-log-unit increase in TNFα was associated with all cancers (aHR = 1.23; 95% CI, 1.00-1.52) and lung cancer (aHR = 1.45, 95% CI, 1.00-2.15); insulin (aHR = 1.46; 95% CI, 1.04-2.05) and CRP (aHR = 1.20, 95% CI, 1.00-1.44) with colorectal cancer; and adiponectin (aHR = 3.27; 95% CI, 1.64-6.52), insulin (aHR = 1.86; 95% CI, 1.03-3.38), and IL-8 (aHR = 1.81; 95% CI, 1.00-3.30) with liver cancer.
conclusionsThe prediagnostic plasma level of TNFα was associated with lung cancer; CRP, insulin, and leptin were associated with colorectal cancer. IMPACT: Inflammation and obesity biomarkers can identify high-risk individuals for targeted interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.